[vc_row inner_container=”true” no_margin=”true” padding_top=”0px” padding_bottom=”0px” border=”none”][vc_column width=”” style=”margin-right: 34px;”][srp post_limit=”1″ widget_title=”” thumbnail_height=”300″ thumbnail_width=”300″ wp_thumbnail_size=”medium” ext_shortcodes_compatibility=”yes” post_content_length=”” post_content_length_mode=”” post_content_type=”” post_title_length_mode=”words” string_break=”” title_string_break=”” post_author_url=”no” post_category_link=”no” widget_title_hide=”yes” post_title_header=”h3″][/vc_column][/vc_row]

As first-ever Marburg outbreak in Tanzania evolves, Aldatu leads the way with pan-filovirus testing for universal access.​

Aldatu Biosciences, a biotechnology company developing molecular diagnostic assays and products based on gold standard real-time PCR, today announced it has been awarded a $3 Million Direct-to-Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). The award will fund the continued advancement of the company’s proprietary PANDAA™ technology platform and its specific application to the universal, pan-lineage detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV), the causative agent of Crimean Congo Hemorrhagic Fever (CCHF).

Read More »

Aldatu Biosciences Adds Another Outbreak Disease to Pandemic Preparedness Portfolio

Aldatu Biosciences, a biotechnology company developing molecular diagnostic assays and products based on gold standard real-time PCR, today announced it has been awarded a $3 Million Direct-to-Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). The award will fund the continued advancement of the company’s proprietary PANDAA™ technology platform and its specific application to the universal, pan-lineage detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV), the causative agent of Crimean Congo Hemorrhagic Fever (CCHF).

Read More »

Senior Research Associate

The Person and Role We are seeking highly-motivated and talented senior research associate to join our Assay Development team. Successful applicants will possess strong molecular biology skills and a demonstrated

Read More »
News

Aldatu Biosciences Expands PANDAA Platform Beyond HIV with SBIR for the First Pan-Lineage Lassa Fever Test

Aldatu Biosciences, a biotechnology company developing molecular diagnostic assays and products based on gold standard real-time PCR, today announced it has been awarded a $300K Phase I SBIR grant from the NIAID at the NIH to fund the continued advancement of the company’s proprietary PANDAA™ technology platform and its specific application to the universal, pan-lineage detection of Lassa virus, the causative agent of Lassa fever.

Read More »